270 related articles for article (PubMed ID: 21062981)
21. The nuclear matrix protein, NRP/B, enhances Nrf2-mediated oxidative stress responses in breast cancer cells.
Seng S; Avraham HK; Jiang S; Yang S; Sekine M; Kimelman N; Li H; Avraham S
Cancer Res; 2007 Sep; 67(18):8596-604. PubMed ID: 17875699
[TBL] [Abstract][Full Text] [Related]
22. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q
J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900
[TBL] [Abstract][Full Text] [Related]
23. Natural dietary anti-cancer chemopreventive compounds: redox-mediated differential signaling mechanisms in cytoprotection of normal cells versus cytotoxicity in tumor cells.
Nair S; Li W; Kong AN
Acta Pharmacol Sin; 2007 Apr; 28(4):459-72. PubMed ID: 17376285
[TBL] [Abstract][Full Text] [Related]
24. NRF2 Intensifies Host Defense Systems to Prevent Lung Carcinogenesis, but After Tumor Initiation Accelerates Malignant Cell Growth.
Satoh H; Moriguchi T; Saigusa D; Baird L; Yu L; Rokutan H; Igarashi K; Ebina M; Shibata T; Yamamoto M
Cancer Res; 2016 May; 76(10):3088-96. PubMed ID: 27020858
[TBL] [Abstract][Full Text] [Related]
25. Lactate dehydrogenase B is critical for hyperactive mTOR-mediated tumorigenesis.
Zha X; Wang F; Wang Y; He S; Jing Y; Wu X; Zhang H
Cancer Res; 2011 Jan; 71(1):13-8. PubMed ID: 21199794
[TBL] [Abstract][Full Text] [Related]
26. Knockdown of NF-E2-related factor 2 inhibits the proliferation and growth of U251MG human glioma cells in a mouse xenograft model.
Ji XJ; Chen SH; Zhu L; Pan H; Zhou Y; Li W; You WC; Gao CC; Zhu JH; Jiang K; Wang HD
Oncol Rep; 2013 Jul; 30(1):157-64. PubMed ID: 23673813
[TBL] [Abstract][Full Text] [Related]
27. NRF2 inhibition represses ErbB2 signaling in ovarian carcinoma cells: implications for tumor growth retardation and docetaxel sensitivity.
Manandhar S; Choi BH; Jung KA; Ryoo IG; Song M; Kang SJ; Choi HG; Kim JA; Park PH; Kwak MK
Free Radic Biol Med; 2012 May; 52(9):1773-85. PubMed ID: 22387177
[TBL] [Abstract][Full Text] [Related]
28. LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in
Galan-Cobo A; Sitthideatphaiboon P; Qu X; Poteete A; Pisegna MA; Tong P; Chen PH; Boroughs LK; Rodriguez MLM; Zhang W; Parlati F; Wang J; Gandhi V; Skoulidis F; DeBerardinis RJ; Minna JD; Heymach JV
Cancer Res; 2019 Jul; 79(13):3251-3267. PubMed ID: 31040157
[TBL] [Abstract][Full Text] [Related]
29. MT477 acts in tumor cells as an AURKA inhibitor and strongly induces NRF-2 signaling.
Jasinski P; Zwolak P; Terai K; Vogel RI; Borja-Cacho D; Dudek AZ
Anticancer Res; 2011 Apr; 31(4):1181-7. PubMed ID: 21508363
[TBL] [Abstract][Full Text] [Related]
30. Genotype analysis of the NRF2 gene mutation in lung cancer.
Sasaki H; Suzuki A; Shitara M; Hikosaka Y; Okuda K; Moriyama S; Yano M; Fujii Y
Int J Mol Med; 2013 May; 31(5):1135-8. PubMed ID: 23545629
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of genes orchestrating keratinocyte differentiation, including the novel marker gene ID2, by contact sensitizers in human bulge-derived keratinocytes.
Yoshikawa Y; Sasahara Y; Kitano Y; Kanazawa N; Shima H; Hashimoto-Tamaoki T
J Biochem Mol Toxicol; 2010; 24(1):10-20. PubMed ID: 20146380
[TBL] [Abstract][Full Text] [Related]
32. Loss-of-function mutations in KEAP1 drive lung cancer progression via KEAP1/NRF2 pathway activation.
Gong M; Li Y; Ye X; Zhang L; Wang Z; Xu X; Shen Y; Zheng C
Cell Commun Signal; 2020 Jun; 18(1):98. PubMed ID: 32576270
[TBL] [Abstract][Full Text] [Related]
33. Nrf2 Transcription Factor Can Directly Regulate mTOR: LINKING CYTOPROTECTIVE GENE EXPRESSION TO A MAJOR METABOLIC REGULATOR THAT GENERATES REDOX ACTIVITY.
Bendavit G; Aboulkassim T; Hilmi K; Shah S; Batist G
J Biol Chem; 2016 Dec; 291(49):25476-25488. PubMed ID: 27784786
[TBL] [Abstract][Full Text] [Related]
34. A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer.
Choi EJ; Jung BJ; Lee SH; Yoo HS; Shin EA; Ko HJ; Chang S; Kim SY; Jeon SM
Oncogene; 2017 Sep; 36(37):5285-5295. PubMed ID: 28504720
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of miR-144 is associated with colorectal cancer progression via activation of mTOR signaling pathway.
Iwaya T; Yokobori T; Nishida N; Kogo R; Sudo T; Tanaka F; Shibata K; Sawada G; Takahashi Y; Ishibashi M; Wakabayashi G; Mori M; Mimori K
Carcinogenesis; 2012 Dec; 33(12):2391-7. PubMed ID: 22983984
[TBL] [Abstract][Full Text] [Related]
36. MetaLnc9 Facilitates Lung Cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway.
Yu T; Zhao Y; Hu Z; Li J; Chu D; Zhang J; Li Z; Chen B; Zhang X; Pan H; Li S; Lin H; Liu L; Yan M; He X; Yao M
Cancer Res; 2017 Nov; 77(21):5782-5794. PubMed ID: 28923857
[TBL] [Abstract][Full Text] [Related]
37. ERBB3 and IGF1R Signaling Are Required for Nrf2-Dependent Growth in KEAP1-Mutant Lung Cancer.
Vartanian S; Lee J; Klijn C; Gnad F; Bagniewska M; Schaefer G; Zhang D; Tan J; Watson SA; Liu L; Chen H; Liang Y; Watanabe C; Cuellar T; Kan D; Hartmaier RJ; Lau T; Costa MR; Martin SE; Merchant M; Haley B; Stokoe D
Cancer Res; 2019 Oct; 79(19):4828-4839. PubMed ID: 31416841
[TBL] [Abstract][Full Text] [Related]
38. Recurrent Loss of NFE2L2 Exon 2 Is a Mechanism for Nrf2 Pathway Activation in Human Cancers.
Goldstein LD; Lee J; Gnad F; Klijn C; Schaub A; Reeder J; Daemen A; Bakalarski CE; Holcomb T; Shames DS; Hartmaier RJ; Chmielecki J; Seshagiri S; Gentleman R; Stokoe D
Cell Rep; 2016 Sep; 16(10):2605-2617. PubMed ID: 27568559
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological, microenvironmental and genetic determinants of molecular subtypes in KEAP1/NRF2-mutant lung cancer.
Cai MC; Chen M; Ma P; Wu J; Lu H; Zhang S; Liu J; Zhao X; Zhuang G; Yu Z; Fu Y
Int J Cancer; 2019 Feb; 144(4):788-801. PubMed ID: 30411339
[TBL] [Abstract][Full Text] [Related]
40. Genetic dissection of the Nrf2-dependent redox signaling-regulated transcriptional programs of cell proliferation and cytoprotection.
Reddy NM; Kleeberger SR; Yamamoto M; Kensler TW; Scollick C; Biswal S; Reddy SP
Physiol Genomics; 2007 Dec; 32(1):74-81. PubMed ID: 17895394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
